JP2025510623A5 - - Google Patents

Info

Publication number
JP2025510623A5
JP2025510623A5 JP2024554796A JP2024554796A JP2025510623A5 JP 2025510623 A5 JP2025510623 A5 JP 2025510623A5 JP 2024554796 A JP2024554796 A JP 2024554796A JP 2024554796 A JP2024554796 A JP 2024554796A JP 2025510623 A5 JP2025510623 A5 JP 2025510623A5
Authority
JP
Japan
Prior art keywords
antibody conjugate
conjugate according
pharmaceutically acceptable
antibody
fuc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024554796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510623A (ja
JP7881734B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/057560 external-priority patent/WO2023180484A1/en
Publication of JP2025510623A publication Critical patent/JP2025510623A/ja
Publication of JP2025510623A5 publication Critical patent/JP2025510623A5/ja
Application granted granted Critical
Publication of JP7881734B2 publication Critical patent/JP7881734B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024554796A 2022-03-23 2023-03-23 Ptk7を発現する腫瘍を標的化するための抗体コンジュゲート Active JP7881734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22163924.8 2022-03-23
EP22163924 2022-03-23
PCT/EP2023/057560 WO2023180484A1 (en) 2022-03-23 2023-03-23 Antibody-conjugates for targeting of tumours expressing ptk7

Publications (3)

Publication Number Publication Date
JP2025510623A JP2025510623A (ja) 2025-04-15
JP2025510623A5 true JP2025510623A5 (cg-RX-API-DMAC10.html) 2026-03-31
JP7881734B2 JP7881734B2 (ja) 2026-06-29

Family

ID=81308370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024554796A Active JP7881734B2 (ja) 2022-03-23 2023-03-23 Ptk7を発現する腫瘍を標的化するための抗体コンジュゲート

Country Status (10)

Country Link
US (1) US12440573B2 (cg-RX-API-DMAC10.html)
EP (1) EP4496592A1 (cg-RX-API-DMAC10.html)
JP (1) JP7881734B2 (cg-RX-API-DMAC10.html)
KR (1) KR20250024742A (cg-RX-API-DMAC10.html)
CN (1) CN120826241A (cg-RX-API-DMAC10.html)
AU (1) AU2023237619A1 (cg-RX-API-DMAC10.html)
CA (1) CA3254479A1 (cg-RX-API-DMAC10.html)
IL (1) IL315366A (cg-RX-API-DMAC10.html)
MX (1) MX2024011518A (cg-RX-API-DMAC10.html)
WO (1) WO2023180484A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3876998A1 (en) 2018-11-05 2021-09-15 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
JP2025533758A (ja) * 2022-10-14 2025-10-09 スーチュアン・コールン-バイオテック・バイオファーマシューティカル・カンパニー・リミテッド 抗体-薬物複合体並びにその調製方法及び使用
EP4737483A1 (en) * 2023-06-30 2026-05-06 Daiichi Sankyo Company, Limited Antibody-drug conjugate production method including purification step using activated carbon material
EP4566631A1 (en) * 2023-12-06 2025-06-11 Heidelberg Pharma Research GmbH New antibody drug conjugate as well as methods of production and uses thereof
CN121800878A (zh) * 2025-12-30 2026-04-07 上海核舟医药有限公司 Ptk7靶向药物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
NZ569236A (en) 2005-12-08 2012-06-29 Medarex Inc Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use
US20070249014A1 (en) 2006-02-10 2007-10-25 Invitrogen Corporation Labeling and detection of post translationally modified proteins
EP2229187A2 (en) * 2007-11-30 2010-09-22 Bristol-Myers Squibb Company Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7)
US20090162359A1 (en) * 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
WO2009102820A2 (en) 2008-02-11 2009-08-20 Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services Modified sugar substrates and methods of use
HRP20180268T4 (hr) 2012-10-23 2026-03-27 Synaffix B.V. Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
SG10201902571VA (en) 2013-12-25 2019-04-29 Daiichi Sankyo Co Ltd Anti-trop2 antibody-drug conjugate
SMT202100146T1 (it) 2014-04-30 2021-05-07 Pfizer Coniugati di anticorpo anti-ptk7-farmaco
EP3177633B1 (en) 2014-08-04 2022-07-20 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
EP3733209A1 (en) 2014-10-03 2020-11-04 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
CN107810273B (zh) 2015-04-23 2022-09-27 西纳福克斯股份有限公司 用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法
WO2017137457A1 (en) * 2016-02-08 2017-08-17 Synaffix B.V. Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates
WO2017137456A1 (en) * 2016-02-08 2017-08-17 Synaffix B.V. Bioconjugates containing sulfamide linkers for use in treatment
WO2017137458A1 (en) * 2016-02-08 2017-08-17 Synaffix B.V. Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates
CA3026651A1 (en) 2016-06-09 2017-12-14 Blinkbio, Inc. Silanol based therapeutic payloads
JP6888764B2 (ja) 2016-12-29 2021-06-16 ディヴェロップメント センター フォー バイオテクノロジー 糖タンパク質−薬物コンジュゲートを調製する方法
EP3720504A1 (en) 2017-12-06 2020-10-14 Synaffix B.V. Enediyne conjugates
TWI920652B (zh) 2018-06-07 2026-04-01 美商思進公司 喜樹鹼結合物
EP3876998A1 (en) 2018-11-05 2021-09-15 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
US12146157B2 (en) * 2018-11-07 2024-11-19 Crispr Therapeutics Ag Anti-PTK7 immune cell cancer therapy
KR20240104214A (ko) 2019-03-29 2024-07-04 메디뮨 리미티드 화합물 및 이의 접합체
RS64961B1 (sr) 2019-04-26 2024-01-31 Immunogen Inc Derivati kamptotecina
KR20230021018A (ko) 2020-06-05 2023-02-13 재단법인 생물기술개발중심 항-메조텔린 항체를 함유하는 항체-약물 컨쥬게이트 및 이의 용도
NL2026400B1 (en) * 2020-09-02 2022-05-04 Synaffix Bv Methods for the preparation of bioconjugates
JP7904824B2 (ja) 2020-09-15 2026-08-13 シンアフィックス ビー.ブイ. 抗体-エクサテカンコンジュゲート
NL2026947B1 (en) 2020-11-20 2022-07-01 Synaffix Bv Tyrosine-based antibody conjugates
CN113816969B (zh) 2021-04-30 2024-01-16 联宁(苏州)生物制药有限公司 依喜替康类化合物、其抗体药物偶联物及其应用
US12533419B2 (en) 2021-07-19 2026-01-27 Mabplex International Co., Ltd. Antibody drug conjugate loaded with binary toxins and its application
MX2024011519A (es) 2022-03-23 2024-09-24 Synaffix Bv Conjugados de anticuerpos para el direccionamiento contra tumores que expresan el antigeno carcinoembrionario.
CA3253220A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. ANTIBODIES CONJUGATED FOR TARGETING TUMORS EXPRESSING TROP-2

Similar Documents

Publication Publication Date Title
JP2025510678A5 (cg-RX-API-DMAC10.html)
JP2020189977A5 (cg-RX-API-DMAC10.html)
JP6733993B2 (ja) スルファミドリンカー、スルファミドリンカーのコンジュゲート、及び調製の方法
US6573245B1 (en) Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
US6960344B2 (en) Use of imine-forming polysaccharides as adjuvants and immunostimulants
JP2020000252A5 (cg-RX-API-DMAC10.html)
EP0180564B1 (en) Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
AU2007343610B2 (en) Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Ni et al. Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates
US6071532A (en) Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
NZ755831A (en) Polypeptide-antigen conjugates with non-natural amino acids
CN1596129A (zh) 多糖结合物形式的含有氨基糖的水溶性抗生素
JPWO2021049504A5 (cg-RX-API-DMAC10.html)
JP2005530493A5 (cg-RX-API-DMAC10.html)
JP2024544959A5 (cg-RX-API-DMAC10.html)
JP2908558B2 (ja) 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法
JP2025510700A5 (cg-RX-API-DMAC10.html)
Warren et al. Synthetic glycopeptide-based vaccines
ES2338558T3 (es) Nuevos derivados de ciclodextrinas, su procedimiento de preparacion y su utilizacion en particular para la solubilizacion de sustancias farmacologicamente activas.
KR890016059A (ko) 포스포노알킬퓨린 유도체
CA2376164A1 (en) Intermolecularly associating compounds, and aggregates comprising them
JP2013505302A (ja) イヌリンの新たな多形形態エプシロン・イヌリンおよびその組成物
CA2354928A1 (en) Non-mucin type synthetic compounds or it's carrier conjugated compounds
EP2890703B1 (en) Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics
JP2001503437A (ja) 1―チオガラクトース誘導体